Publications by authors named "Saul Genuth"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,647,152

Total Likes

38,950

Extended Reach

2,794,888

Social Features

155
E
Effects of intensive glucose lowering in type 2 diabetes.

N Engl J Med· June 2008

Videos about Article: user user user 17

20 10 135 26 29

View All Article and Social Media Activity
P
Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC.
Vincent M Monnier, David R Sell, Xiaoyu Gao, Saul M Genuth, John M Lachin

BMJ Open Diabetes Res Care· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BARI 2D: A Reanalysis Focusing on Cardiovascular Events.
Saul M Genuth, Helen Vlachos, Maria Mori Brooks, John P Bantle, Bernard R Chaitman

Mayo Clin Proc· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of and Its Contributions to the Field of Diabetes: A Profile in Progress.
Lyn Reynolds, Saul M Genuth

Diabetes Care· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
Rodica Pop-Busui, Barbara H Braffett, Bernie Zinman, Catherine Martin, Neil H White, Saul Genuth

Diabetes Care· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes.
Vincent M Monnier, Saul Genuth, David R Sell

Glycoconj J· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort.
Zhuo Chen, Feng Miao, Andrew D Paterson, John M Lachin, Lingxiao Zhang, Saul Genuth

Proc Natl Acad Sci U S A· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triglyceride High-Density Lipoprotein Ratios Predict Glycemia-Lowering in Response to Insulin Sensitizing Drugs in Type 2 Diabetes: A Post Hoc Analysis of the BARI 2D.
Joel Zonszein, Manuel Lombardero, Faramarz Ismail-Beigi, Pasquale Palumbo, Suzy Foucher, Saul Genuth

J Diabetes Res· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes.
David R Sell, Wanjie Sun, Xiaoyu Gao, Christopher Strauch, John M Lachin, Saul Genuth

Cardiovasc Diabetol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin Dose and Cardiovascular Mortality in the ACCORD Trial.
Elias S Siraj, Daniel J Rubin, Matthew C Riddle, Michael E Miller, Fang-Chi Hsu, Saul Genuth

Diabetes Care· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
Vincent M Monnier, Wanjie Sun, Xiaoyu Gao, David R Sell, Patricia A Cleary, Saul Genuth

Cardiovasc Diabetol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data sharing is desirable, but benefits should not be exaggerated.
David M Nathan, Saul M Genuth, Bernard Zinman, John M Lachin

BMJ· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The diabetes control and complications trial/epidemiology of diabetes interventions and complications study: 30th anniversary presentations.
Bernard Zinman, Saul Genuth, David M Nathan

Diabetes Care· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
Vincent M Monnier, Wanjie Sun, Xiaoyu Gao, David R Sell, Patricia A Cleary, Saul Genuth

Cardiovasc Diabetol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to comment on Genuth. Should sulfonylureas remain an acceptable first-line add-on to metformin therapy in patients with type 2 diabetes? No, it's time to move on! Diabetes Care 2015;38:170-175.
Saul Genuth

Diabetes Care· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.
Saul Genuth, Wanjie Sun, Patricia Cleary, Xiaoyu Gao, David R Sell

Diabetes· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should sulfonylureas remain an acceptable first-line add-on to metformin therapy in patients with type 2 diabetes? No, it's time to move on!
Saul Genuth

Diabetes Care· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study.
Emily Y Chew, Matthew D Davis, Ronald P Danis, James F Lovato, Letitia H Perdue, Saul Genuth

Ophthalmology· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-reported prevalence of diabetes screening in the U.S., 2005-2010.
Sarah Stark Casagrande, Catherine C Cowie, Saul M Genuth

Am J Prev Med· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes.
Feng Miao, Zhuo Chen, Saul Genuth, Andrew Paterson, Lingxiao Zhang

Diabetes· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial".
Richard G Bach, Maria Mori Brooks, Manuel Lombardero, Saul Genuth, Thomas W Donner

Circulation· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications.
Vincent M Monnier, Wanjie Sun, David R Sell, Xingjun Fan, Ina Nemet, Saul Genuth

Clin Chem Lab Med· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions.
David M Nathan, Margaret Bayless, Patricia Cleary, Saul Genuth, Rose Gubitosi-Klug

Diabetes· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How does pioglitazone prevent progression of impaired glucose tolerance to diabetes?
Saul M Genuth

Diabetes· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Richard G Bach, Maria Mori Brooks, Manuel Lombardero, Saul Genuth, Thomas W Donner

Circulation· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis